Gilder Gagnon Howe & CO LLC Rocket Pharmaceuticals, Inc. Transaction History

Gilder Gagnon Howe & CO LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$26.16 - $30.74 $2,851 - $3,350	-109 Reduced 0.56%	19,270 $519,000
Q4 2023 Feb 14, 2024	BUY	$16.78 - $31.94 $7,970 - $15,171	475 Added 2.51%	19,379 $580,000
Q3 2023 Nov 14, 2023	SELL	$15.07 - $24.05 $67,573 - $107,840	-4,484 Reduced 19.17%	18,904 $387,000
Q2 2023 Aug 14, 2023	SELL	$16.59 - $23.6 $995 - $1,416	-60 Reduced 0.26%	23,388 $464,000
Q1 2023 May 15, 2023	BUY	$15.79 - $22.6 $52,091 - $74,557	3,299 Added 16.37%	23,448 $401,000
Q4 2022 Feb 14, 2023	BUY	$15.5 - $22.76 $312,309 - $458,591	20,149 New	20,149 $394,000
Q2 2022 Aug 15, 2022	BUY	$7.96 - $16.64 $236,085 - $493,525	29,659 New	29,659 $408,000

209

93.2M

319K

70.3K

Ticker RCKT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 75,683,696
Market Cap $1.02B
Description
Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...

Get notified when there are updates to the investment portfolio of Gilder Gagnon Howe & CO LLC, based on Form 13F filings with the SEC.

Stay updated on Gilder Gagnon Howe & CO LLC with notifications on news.